Search research articles
Contact Us
Filters
Showing results (131-140 of 139) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 139 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 17, 2021
Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapy
A Cortellini, B Ricciuti, F Facchinetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 17, 2025
Next-Generation Multicenter Studies: Using Artificial Intelligence to Automatically Process Unstructured Health Records of Patients with Lung Cancer across Multiple Institutions
M Aldea, L Zullo, V Levrat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2022
Liquid versus tissue biopsy for detecting actionable alterations according to the ESMO Scale for Clinical Actionability of molecular Targets in patients with advanced cancer: a study from the French National Center for Precision Medicine (PRISM)
A Bayle, F Peyraud, L Belcaid, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 24, 2020
Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts
P M Putora, G F Fischer, M Früh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 28, 2023
Clinical utility of circulating tumor DNA sequencing with a large panel: a National Center for Precision Medicine (PRISM) study
A Bayle, L Belcaid, M Aldea, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2025
ESMO basic requirements for AI-based biomarkers in oncology (EBAI)
M Aldea, M Salto-Tellez, A Marra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 25, 2019
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
J Mazieres, A Drilon, A Lusque, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2026
MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted Therapies
M Aldea, S Lenahan, M-A Locquet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 28, 2024
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA
E Felip, B C Cho, V Gutiérrez, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 139) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 139 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 17, 2021
Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapy
A Cortellini, B Ricciuti, F Facchinetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 17, 2025
Next-Generation Multicenter Studies: Using Artificial Intelligence to Automatically Process Unstructured Health Records of Patients with Lung Cancer across Multiple Institutions
M Aldea, L Zullo, V Levrat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2022
Liquid versus tissue biopsy for detecting actionable alterations according to the ESMO Scale for Clinical Actionability of molecular Targets in patients with advanced cancer: a study from the French National Center for Precision Medicine (PRISM)
A Bayle, F Peyraud, L Belcaid, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 24, 2020
Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts
P M Putora, G F Fischer, M Früh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 28, 2023
Clinical utility of circulating tumor DNA sequencing with a large panel: a National Center for Precision Medicine (PRISM) study
A Bayle, L Belcaid, M Aldea, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2025
ESMO basic requirements for AI-based biomarkers in oncology (EBAI)
M Aldea, M Salto-Tellez, A Marra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 25, 2019
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
J Mazieres, A Drilon, A Lusque, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2026
MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted Therapies
M Aldea, S Lenahan, M-A Locquet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 28, 2024
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA
E Felip, B C Cho, V Gutiérrez, et al.
Page
of 14